McMahon Gerald PhD 4
4 · Celldex Therapeutics, Inc. · Filed Jun 15, 2018
Insider Transaction Report
Form 4
McMahon Gerald PhD
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2018-06-13+67,000→ 67,000 totalExercise: $0.60From: 2019-06-13Exp: 2028-06-13→ Common Stock (67,000 underlying)
Footnotes (1)
- [F1]Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.